News Digest / Ticker: KPTI

Ticker: KPTI

09:30am, Tuesday, Mar 24, 2026

Karyopharm Shares Jump 10% Following Mixed Phase 3 Trial Outcomes on Myelofibrosis Treatment

Karyopharm Therapeutics saw a 10% stock increase after Phase 3 trial data showed significant spleen volume reduction but no symptom improvement in myelofibrosis patients treated with selinexor plus ruxolitinib.

08:03am, Monday, Aug 11, 2025

Karyopharm cuts 20% of staff, pursues strategic and financing options amid cash crunch